Cost-effectiveness of the second COVID-19 booster vaccination in the United States https://www.medrxiv.org/content/10.1101/2022.12.28.22283986
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.